Professional Compounding Centers of America, Inc. (PCCA)'s shares of Imprimis Pharmaceuticals, Inc: Initial SEC Filings

because copy of actual page does not fit nicely on page, link is also provided  here

Filing Detail

• SEC Home »
 
• Search the Next-Generation EDGAR System »
 
• Company Search »
 
• Current Page

Form 3 - Initial statement of beneficial ownership of securities

SEC Accession No. 0001078782-13-000418

Filing Date

2013-03-08

Accepted

2013-03-08 19:39:15

Documents

1

Period of Report

2012-08-31

Filing Date Changed

2013-03-08

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	3
1	PRIMARY DOCUMENT	primary_doc.xml	3	2068
	Complete submission text file	0001078782-13-000418.txt		3850

Mailing Address437 S. HWY 101STE 209SOLANA BEACH CA 92075

Business Address437 S. HWY 101STE 209SOLANA BEACH CA 92075858-433-2800

Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address9901 S. WILCREST DR.HOUSTON TX 77099

Business Address9901 S. WILCREST DR.HOUSTON TX 77099281-933-6948

Professional Compounding Centers of America, Inc. (Reporting) CIK: 0001558044 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35814 | Film No.: 13678993